Additional information
White Powder
265989-44-4
ACI-011225
208.2-209.0°C
C33H34FN2NaO6
596.62
Ambient
2-8°C
Cardiovascular
Pharmaceutical Impurity Standards
(ßR,dR)-2-(4-fluorophenyl)-ß,d-dihydroxy-4-[[(4-hydroxyphenyl)amino]carbonyl]-5-(1-methylethyl)-3-phenyl-1H-Pyrrole-1-heptanoic acid sodium salt
(ßR,dR)-2-(4-fluorophenyl)-ß,d-dihydroxy-4-[[(4-hydroxyphenyl)amino]carbonyl]-5-(1-methylethyl)-3-phenyl-1H-Pyrrole-1-heptanoic acid sodium salt
4-Hydroxy atorvastatin





![6,9-DIACYL PACLITAXEL (25 mg) ((2aR,4S,4aS,6R,9S,11S,12S,12aR,12bS)-12b-Acetoxy-12-(benzoyloxy)-4,11-dihydroxy-4a,8,13,13-tetramethyl-5-oxo-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-1H-7,11-methanocyclodeca[3,4]benzo[1,2-b]oxete-6,9-diyl (2R,2'R,3S,3'S)-bis(3-benzamido-2-hydroxy-3-phenylpropanoate))](https://analyticachemie.in/ver-2/wp-content/uploads/uspimage-1.jpg)